Modification of treatment strategy after FFR measurement: CVIT-DEFER registry.

Cardiovascular intervention and therapeutics

PubMedID: 24816634

Nakamura M, Yamagishi M, Ueno T, Hara K, Ishiwata S, Itoh T, Hamanaka I, Wakatsuki T, Sugano T, Kawai K, Akasaka T, Tanaka N, Kimura T. Modification of treatment strategy after FFR measurement: CVIT-DEFER registry. Cardiovasc Interv Ther. 2015;30(1):12-21.
The impact of the fractional flow reserve (FFR) on clinical decision-making remains unclear in daily practice. The CVIT-DEFER registry is a prospective multicenter registry enrolling consecutive patients with angiographically intermediate coronary stenosis for whom FFR measurement is clinically indicated. The treatment strategy determined from angiographic findings alone and the strategy selected after FFR measurement were compared. DATA
on the treatment strategy were obtained for 3093 subjects.The average age of these subjects was 69. 5 ± 10. 2 years and 73. 8 % were men. The majority had stable coronary artery disease, including 60. 4 % with stable angina pectoris. The treatment strategy based on angiographic findings was medical management in 34. 5 %, percutaneous coronary intervention (PCI) in 63. 5 %, and coronary artery bypass grafting in 2. 1 %. The FFR was =0. 8 in 1566 lesions (42. 2 %). After FFR measurement, medical treatment was changed to revascularization in 19. 7 %, while PCI was switched to medical treatment in 57. 4 % at the lesion level. As a result, reclassification of the treatment strategy at the patient level was done in 39. 0 % of the patients. Revascularization was frequently switched to medical treatment after FFR measurement. These findings support the clinical utility of employing FFR data to guide selection of PCI.